Report for Joossens J

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (6)

Title : Extended structure-activity relationship and pharmacokinetic investigation of (4-quinolinoyl)glycyl-2-cyanopyrrolidine inhibitors of fibroblast activation protein (FAP) - Jansen_2014_J.Med.Chem_57_3053
Author(s) : Jansen K , Heirbaut L , Verkerk R , Cheng JD , Joossens J , Cos P , Maes L , Lambeir AM , De Meester I , Augustyns K , Van der Veken P
Ref : Journal of Medicinal Chemistry , 57 :3053 , 2014
Abstract : Jansen_2014_J.Med.Chem_57_3053
ESTHER : Jansen_2014_J.Med.Chem_57_3053
PubMedSearch : Jansen_2014_J.Med.Chem_57_3053
PubMedID: 24617858

Title : Selective Inhibitors of Fibroblast Activation Protein (FAP) with a (4-Quinolinoyl)-glycyl-2-cyanopyrrolidine Scaffold - Jansen_2013_ACS.Med.Chem.Lett_4_491
Author(s) : Jansen K , Heirbaut L , Cheng JD , Joossens J , Ryabtsova O , Cos P , Maes L , Lambeir AM , De Meester I , Augustyns K , Van der Veken P
Ref : ACS Med Chem Lett , 4 :491 , 2013
Abstract : Jansen_2013_ACS.Med.Chem.Lett_4_491
ESTHER : Jansen_2013_ACS.Med.Chem.Lett_4_491
PubMedSearch : Jansen_2013_ACS.Med.Chem.Lett_4_491
PubMedID: 24900696

Title : P2-substituted N-acylprolylpyrrolidine inhibitors of prolyl oligopeptidase: biochemical evaluation, binding mode determination, and assessment in a cellular model of synucleinopathy - Van der Veken_2012_J.Med.Chem_55_9856
Author(s) : Van der Veken P , Fulop V , Rea D , Gerard M , Van Elzen R , Joossens J , Cheng JD , Baekelandt V , De Meester I , Lambeir AM , Augustyns K
Ref : Journal of Medicinal Chemistry , 55 :9856 , 2012
Abstract : Van der Veken_2012_J.Med.Chem_55_9856
ESTHER : Van der Veken_2012_J.Med.Chem_55_9856
PubMedSearch : Van der Veken_2012_J.Med.Chem_55_9856
PubMedID: 23121075
Gene_locus related to this paper: pig-ppce

Title : Acylated Gly-(2-cyano)pyrrolidines as inhibitors of fibroblast activation protein (FAP) and the issue of FAP\/prolyl oligopeptidase (PREP)-selectivity - Ryabtsova_2012_Bioorg.Med.Chem.Lett_22_3412
Author(s) : Ryabtsova O , Jansen K , Van Goethem S , Joossens J , Cheng JD , Lambeir AM , De Meester I , Augustyns K , Van der Veken P
Ref : Bioorganic & Medicinal Chemistry Lett , 22 :3412 , 2012
Abstract : Ryabtsova_2012_Bioorg.Med.Chem.Lett_22_3412
ESTHER : Ryabtsova_2012_Bioorg.Med.Chem.Lett_22_3412
PubMedSearch : Ryabtsova_2012_Bioorg.Med.Chem.Lett_22_3412
PubMedID: 22525314

Title : Structure-activity relationship studies on isoindoline inhibitors of dipeptidyl peptidases 8 and 9 (DPP8, DPP9): is DPP8-selectivity an attainable goal? - Van Goethem_2011_J.Med.Chem_54_5737
Author(s) : Van Goethem S , Matheeussen V , Joossens J , Lambeir AM , Chen X , De Meester I , Haemers A , Augustyns K , Van der Veken P
Ref : Journal of Medicinal Chemistry , 54 :5737 , 2011
Abstract : Van Goethem_2011_J.Med.Chem_54_5737
ESTHER : Van Goethem_2011_J.Med.Chem_54_5737
PubMedSearch : Van Goethem_2011_J.Med.Chem_54_5737
PubMedID: 21711053
Gene_locus related to this paper: human-DPP8 , human-DPP9

Title : Inhibition of dipeptidyl-peptidase IV catalyzed peptide truncation by Vildagliptin ((2S)-{[(3-hydroxyadamantan-1-yl)amino]acetyl}-pyrrolidine-2-carbonitrile) - Brandt_2005_Biochem.Pharmacol_70_134
Author(s) : Brandt I , Joossens J , Chen X , Maes MB , Scharpe S , De Meester I , Lambeir AM
Ref : Biochemical Pharmacology , 70 :134 , 2005
Abstract : Brandt_2005_Biochem.Pharmacol_70_134
ESTHER : Brandt_2005_Biochem.Pharmacol_70_134
PubMedSearch : Brandt_2005_Biochem.Pharmacol_70_134
PubMedID: 15907807